Eli Lillys GLP-1 offering, tirzepatide, launched shortly after (as Mounjaro for T2D in 2022 and Zepbound for obesity in 2023), demonstrated greater HbA1c reduction and up to a 20% placebo-adjusted weight loss
This voluntary model allows manufacturers to enter negotiated agreements with CMS to provide set pricing on their portfolio of covered outpatient drugs using the MFN pricing
A physician-reviewed breakdown of the pharmacokinetic and pharmacodynamic interactions, serotonin syndrome risk, monitoring protocols, and dose-adjustment guidance
Adults with recorded evidence of prior type 1 or type 2 diabetes, myocardial infarction, stroke, or heart failure were excluded from the study
This two-pronged attackrapidly replenishing B vitamins while actively helping to clear out toxinsis what makes a specialized supplement so effective